Pharmacokinetics of 5-aminolevulinic acid-induced protoporphyrin IX in skin and blood

Journal of Photochemistry and Photobiology B: Biology

Volumn 40, Issue 3, 1997, Pages 313-319

  Rick, K ^a   Sroka, R ^a   Stepp, H ^a   Kriegmair, M ^a   Huber, R M ^b   Jacob, K ^a   Baumgartner, R ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Fluorescence; Photodynamic diagnosis; Photodynamic therapy; Porphyrins; Side effects

Indexed keywords

AMINOLEVULINIC ACID; PROTOPORPHYRIN;

ADULT; AGED; ARTICLE; BLOOD; BLOOD SAMPLING; CLINICAL ARTICLE; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG TISSUE LEVEL; FLUORESCENCE; HUMAN; HYPOTENSION; INHALATIONAL DRUG ADMINISTRATION; NAUSEA; NEUROLOGIC DISEASE; ORAL DRUG ADMINISTRATION; PHOTODYNAMIC THERAPY; PLASMA; PRIORITY JOURNAL; SIDE EFFECT; SKIN; TOPICAL DRUG ADMINISTRATION; VOMITING;

AGED; AMINOLEVULINIC ACID; FLUORESCENCE; HUMANS; MIDDLE AGED; PROTOPORPHYRINS; SKIN;

EID: 0030701830     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1011-1344(97)00076-6     Document Type: Article

References (29)

1. S.S. Bottomley, U. Müller-Eberhard, Pathophysiology of heme synthesis. Semin. Hematol., 25 (1988) 282-302.
2. M.R. Moore, K.E.L. McColl, C. Rimington, A. Goldberg, Porphyrins and enzymes of the heme biosynthetic pathway, in: Disorders of Porphyrin Metabolism, Plenum, New York, pp. 21-116.
3. N.I. Berlin, A. Neuberger, J.J. Scott, The metabolism of d-aminolaevulinic acid, Biochem. J., 64 (1956) 80-100.
4. A.M. Batlle, Porphyrins, porphyrias, cancer and photodynamic therapy - a model for carcinogenesis. J. Photochem. Photobiol. B: Biol., 20 (1993) 5-22.
5. P. Heil, S. Stocker, R. Sroka, R. Baumgartner, In vivo fluorescence kinetics of porphyrins following intravesical instillation of 5-aminolevulinic acid in normal and tumour bearing rat bladders, J. Photochem. Photobiol. B: Biol., in press.
6. R. Sroka, W. Beyer, L. Gossner, T. Sassy, S. Stocker, R. Baumgartner, Pharmacokinetics of 5-aminolevulinic-acid-induced porphyrins in tumour-bearing mice, J. Photochem. Photobiol. B: Biol., 34 (1996) 13-19.
7. B.W. Henderson, L. Vaughan, D.A. Bellnier, H. Van Leengoed, P.G. Johnson, A.R. Oseroff, Photosensitization of murine tumor, vasculature and skin by 5-aminolevulinic acid-induced porphyrin, Photochem. Photobiol., 62 (1995) 780-789.
8. Z. Hua, S.L. Gibson, T.H. Foster, R. Hilf, Effectiveness of delta-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo, Cancer Res., 55 (1995) 1723-173.
9. S. Iinuma, R. Bachor, T. Flotte, T. Hasan, Biodistribution and phototoxicity of 5-aminolevulinic acid-induced PpIX in an orthotopic rat bladder tumor model, J. Urol., 153 (1995) 802-806.
10. Z. Malik, G. Kostenich, L. Roitman, B. Ehrenberg, A. Orenstein, Topical application of 5-aminolevulinic acid, DMSO and EDTA: protoporphyrin IX accumulation in skin and tumours of mice, J. Photochem. Photobiol. B: Biol., 28 (1995) 213-218.
11. C.S. Loh, A.J. MacRobert, J. Bedwell, J. Regula, N. Krasner, S.G. Bown, Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy, Br. J. Cancer, 68 (1993) 41-51.
12. D.L. Campbell, E.F. Gudgin-Dickson, P.G. Forkert, R.H. Pottier, J.C. Kennedy, Detection of early stages of carcinogenesis in adenomas of murine lung by 5-aminolevulinic acid-induced protoporphyrin IX fluorescence, Photochem. Photobiol., 64 (1996) 676-682.
13. J.C. Kennedy, R.H. Pottier, Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy, J. Photochem. Photobiol. B: Biol., 14 (1992) 275-292.
14. R. Baumgartner, R.M. Huber, H. Schulz, H. Stepp, K. Rick, F. Gamarra, A. Leberig, C. Roth, Inhalation of 5-aminolevulinic acid: a new technique for fluorescence detection of early stage lung cancer, J. Photochem. Photobiol. B: Biol., 36 (1996) 169-174.
15. L. Gossner, R. Sroka, E.G. Hahn, C. Ell, Photodynamic therapy: successful destruction of gastrointestinal cancer after oral administration of aminolevulinic acid, Gastrointesi. Endosc., 41 (1995) 55-58.
16. M. Kriegmair, R. Baumgartner, R. Knuchel, H. Stepp, F. Hofstadter. A. Hofstetter, Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence, J. Urol., 155 (1996) 105-109 (see comments).
17. A. Leunig, K. Rick, H. Stepp, R. Gutmann, A.E. Goetz, R. Baumgartner, J. Feyh, Fluorescence imaging and spectroscopy of 5-aminolevulinic acid induced Protoporphyrin IX for the detection of neoplastic lesions in the oral cavity, Am. J. Surg., in press.
18. J. Regula, A.J. MacRobert, A. Gorchein, G.A. Buonaccorsi, S.M. Thorpe, G.M. Spencer, A.R. Hatfield, S.G. Bown, Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX - a pilot study, Gut, 36 (1995) 67-75.
19. J.M. Wessels, R. Sroka, P. Heil, H.K. Seidlitz, Photodegradation of protoporphyrin-dimethylester in solution and in organized environments, Int. J. Radiat. Biol., 64 (1993) 475-484.
20. K. Tomokuni, M. Ichiba, Y. Hirai, HPLC micro-method for determining delta-aminolevulinic acid in plasma, Clin. Chem., 39 (1993) 169-170.
21. Johannes Siegert, Personal communication, 1995.
22. D.W. Marquardt, An algorithm for least squares of estimation of nonlinear parameters, J. Soc. Ind. Appl. Math., 11 (1963) 431-441.
23. [23 ] S.R. Edwards, B.C. Shanley, J.A. Reynoldson, Neuropharmacology of delta-aminolaevulinic acid - I. Effect of acute administration in rodents, Neuropharmacology, 23 (1984) 477-481.
24. P. Mustajoki, K. Timonen, A. Gorchein, A.M. Seppalainen, E. Matikainen, R. Tenhunen, Sustained high plasma 5-aminolaevulinic acid concentration in a volunteer: no porphyric symptoms, Eur. J. Clin. Invest., 22 (1992) 407-411.
25. D.M. Fiedler, P.M. Eckl, B. Krammer, Does delta-aminolaevulinic acid induce genotoxic effects? J. Photochem. Photobiol. B: Biol., 33 (1996) 39-44.
26. J. Webber, D. Kessel, D. Fromm, Plasma levels of protoporphyrin IX in humans after oral administration of 5-aminolevulinic acid, J. Photochem. Photobiol. B: Biol., 37 (1997) 151-153.
27. M. Doss, Normal ranges of porphyrins and precursors in human tissue, urine and feces, in: J.J.T.W.A. Strik, J.H. Koeman (eds.), Chemical porphyria in man, Elsevier. North-Holland, Biomedical Press, Amsterdam, pp. 221-221.
28. A. Gorchein, R. Webber, δ-Aminolaevulinic acid in plasma, cerebrospinal fluid, saliva and erythrocytes: studies in normal, uraemic and porphyric subjects, Clin. Sci., 72 (1987) 103-112.
29. M. Hermes-Lima, V.G. Valle, A.E. Vercesi, E.J. Bechara, Damage to rat liver mitochondria promoted by delta-aminolevulinic acid-generated reactive oxygen species: connections with acute intermittent porphyria and lead-poisoning, Biochim. Biophys. Acta, 1056 (1991) 57-63.